Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
Identifieur interne : 000342 ( Main/Curation ); précédent : 000341; suivant : 000343Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
Auteurs : Laurence Torcel-Pagnon [France] ; Vincent Bauchau [Belgique] ; Patrick Mahy [Belgique] ; Myint Tin Tin Htar [France] ; Marianne Van Der Sande [Pays-Bas] ; Cédric Mahé [France] ; Tyra Grove Krause [Danemark] ; Anne Charrat [France] ; François Simondon [France] ; Xavier Kurz [Royaume-Uni]Source :
- Vaccine [ 1873-2518 ] ; 2019.
Abstract
The 2009 influenza pandemic highlighted challenges for vaccine post-marketing monitoring in Europe, particularly the need to have appropriate infrastructures to strengthen public-private collaborations (PPCs) with suitable processes to improve stakeholder interactions and collection and analysis of safety and effectiveness data. The ADVANCE consortium comprises public and private stakeholders who have worked together to build and test new system components for vaccine post-marketing projects, one component being a governance framework for efficient, transparent and trustworthy PPCs.
DOI: 10.1016/j.vaccine.2019.04.073
PubMed: 31072735
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000137
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000137
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000145
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001F57
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001F57
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001F57
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :000341
Links to Exploration step
pubmed:31072735Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.</title><author><name sortKey="Torcel Pagnon, Laurence" sort="Torcel Pagnon, Laurence" uniqKey="Torcel Pagnon L" first="Laurence" last="Torcel-Pagnon">Laurence Torcel-Pagnon</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: laurence.pagnon@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bauchau, Vincent" sort="Bauchau, Vincent" uniqKey="Bauchau V" first="Vincent" last="Bauchau">Vincent Bauchau</name><affiliation wicri:level="1"><nlm:affiliation>Vaccine Clinical Safety and Pharmacovigilance, GSK, Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Vaccine Clinical Safety and Pharmacovigilance, GSK, Wavre</wicri:regionArea><wicri:noRegion>Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Mahy, Patrick" sort="Mahy, Patrick" uniqKey="Mahy P" first="Patrick" last="Mahy">Patrick Mahy</name><affiliation wicri:level="3"><nlm:affiliation>Expertise, Service Provision and Customer Relations, Sciensano, Brussels, Belgium. Electronic address: Patrick.Mahy@sciensano.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Expertise, Service Provision and Customer Relations, Sciensano, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Tin Tin Htar, Myint" sort="Tin Tin Htar, Myint" uniqKey="Tin Tin Htar M" first="Myint" last="Tin Tin Htar">Myint Tin Tin Htar</name><affiliation wicri:level="3"><nlm:affiliation>Clinical Epidemiology, Pfizer Inc, Paris, France. Electronic address: Myint.TinTinHtar@pfizer.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Epidemiology, Pfizer Inc, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Van Der Sande, Marianne" sort="Van Der Sande, Marianne" uniqKey="Van Der Sande M" first="Marianne" last="Van Der Sande">Marianne Van Der Sande</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. Electronic address: mvandersande@itg.be.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Mahe, Cedric" sort="Mahe, Cedric" uniqKey="Mahe C" first="Cédric" last="Mahé">Cédric Mahé</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: cedric.mahe@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Krause, Tyra Grove" sort="Krause, Tyra Grove" uniqKey="Krause T" first="Tyra Grove" last="Krause">Tyra Grove Krause</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Denmark. Electronic address: TGV@ssi.dk.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut</wicri:regionArea><wicri:noRegion>Statens Serum Institut</wicri:noRegion></affiliation></author><author><name sortKey="Charrat, Anne" sort="Charrat, Anne" uniqKey="Charrat A" first="Anne" last="Charrat">Anne Charrat</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: anne.charrat@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Simondon, Francois" sort="Simondon, Francois" uniqKey="Simondon F" first="François" last="Simondon">François Simondon</name><affiliation wicri:level="3"><nlm:affiliation>MERIT Research Unit, IRD, Paris, France; Paris Descartes University, Paris, France. Electronic address: francois.simondon@ird.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>MERIT Research Unit, IRD, Paris, France; Paris Descartes University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Kurz, Xavier" sort="Kurz, Xavier" uniqKey="Kurz X" first="Xavier" last="Kurz">Xavier Kurz</name><affiliation wicri:level="3"><nlm:affiliation>Pharmacovigilance & Epidemiology Department, European Medicines Agency, London, UK. Electronic address: xavier.kurz@ema.europa.eu.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Pharmacovigilance & Epidemiology Department, European Medicines Agency, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31072735</idno><idno type="pmid">31072735</idno><idno type="doi">10.1016/j.vaccine.2019.04.073</idno><idno type="wicri:Area/PubMed/Corpus">000137</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000137</idno><idno type="wicri:Area/PubMed/Curation">000137</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000137</idno><idno type="wicri:Area/PubMed/Checkpoint">000145</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000145</idno><idno type="wicri:Area/Ncbi/Merge">001F57</idno><idno type="wicri:Area/Ncbi/Curation">001F57</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F57</idno><idno type="wicri:Area/Main/Merge">000341</idno><idno type="wicri:Area/Main/Curation">000342</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.</title><author><name sortKey="Torcel Pagnon, Laurence" sort="Torcel Pagnon, Laurence" uniqKey="Torcel Pagnon L" first="Laurence" last="Torcel-Pagnon">Laurence Torcel-Pagnon</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: laurence.pagnon@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bauchau, Vincent" sort="Bauchau, Vincent" uniqKey="Bauchau V" first="Vincent" last="Bauchau">Vincent Bauchau</name><affiliation wicri:level="1"><nlm:affiliation>Vaccine Clinical Safety and Pharmacovigilance, GSK, Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Vaccine Clinical Safety and Pharmacovigilance, GSK, Wavre</wicri:regionArea><wicri:noRegion>Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Mahy, Patrick" sort="Mahy, Patrick" uniqKey="Mahy P" first="Patrick" last="Mahy">Patrick Mahy</name><affiliation wicri:level="3"><nlm:affiliation>Expertise, Service Provision and Customer Relations, Sciensano, Brussels, Belgium. Electronic address: Patrick.Mahy@sciensano.be.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Expertise, Service Provision and Customer Relations, Sciensano, Brussels</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Tin Tin Htar, Myint" sort="Tin Tin Htar, Myint" uniqKey="Tin Tin Htar M" first="Myint" last="Tin Tin Htar">Myint Tin Tin Htar</name><affiliation wicri:level="3"><nlm:affiliation>Clinical Epidemiology, Pfizer Inc, Paris, France. Electronic address: Myint.TinTinHtar@pfizer.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Clinical Epidemiology, Pfizer Inc, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Van Der Sande, Marianne" sort="Van Der Sande, Marianne" uniqKey="Van Der Sande M" first="Marianne" last="Van Der Sande">Marianne Van Der Sande</name><affiliation wicri:level="3"><nlm:affiliation>Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. Electronic address: mvandersande@itg.be.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Mahe, Cedric" sort="Mahe, Cedric" uniqKey="Mahe C" first="Cédric" last="Mahé">Cédric Mahé</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: cedric.mahe@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Krause, Tyra Grove" sort="Krause, Tyra Grove" uniqKey="Krause T" first="Tyra Grove" last="Krause">Tyra Grove Krause</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Denmark. Electronic address: TGV@ssi.dk.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut</wicri:regionArea><wicri:noRegion>Statens Serum Institut</wicri:noRegion></affiliation></author><author><name sortKey="Charrat, Anne" sort="Charrat, Anne" uniqKey="Charrat A" first="Anne" last="Charrat">Anne Charrat</name><affiliation wicri:level="3"><nlm:affiliation>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon, France. Electronic address: anne.charrat@sanofi.com.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Vaccine Epidemiology and Modelling (VEM), Sanofi Pasteur, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Simondon, Francois" sort="Simondon, Francois" uniqKey="Simondon F" first="François" last="Simondon">François Simondon</name><affiliation wicri:level="3"><nlm:affiliation>MERIT Research Unit, IRD, Paris, France; Paris Descartes University, Paris, France. Electronic address: francois.simondon@ird.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>MERIT Research Unit, IRD, Paris, France; Paris Descartes University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Kurz, Xavier" sort="Kurz, Xavier" uniqKey="Kurz X" first="Xavier" last="Kurz">Xavier Kurz</name><affiliation wicri:level="3"><nlm:affiliation>Pharmacovigilance & Epidemiology Department, European Medicines Agency, London, UK. Electronic address: xavier.kurz@ema.europa.eu.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Pharmacovigilance & Epidemiology Department, European Medicines Agency, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 2009 influenza pandemic highlighted challenges for vaccine post-marketing monitoring in Europe, particularly the need to have appropriate infrastructures to strengthen public-private collaborations (PPCs) with suitable processes to improve stakeholder interactions and collection and analysis of safety and effectiveness data. The ADVANCE consortium comprises public and private stakeholders who have worked together to build and test new system components for vaccine post-marketing projects, one component being a governance framework for efficient, transparent and trustworthy PPCs.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000342 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000342 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Curation
|type= RBID
|clé= pubmed:31072735
|texte= Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:31072735" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |